Fig. 2From: Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinomaKaplan–Meier analyses of recurrence-free and overall survival of CD44 (a), CD44v6 (b), CD44v8-10 (c), CD133 (d), EpCAM (e), and ALDH1A1 (f) in intrahepatic CCA patientsBack to article page